Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This molecule is a long non-coding RNA (lncRNA) identified as antisense to the SH2D3C gene locus. It is cataloged in genetic databases as ENSG00000299648 and does not produce a protein product[1]. There is no evidence that it serves as a therapeutic target, and no specific biological functions, disease roles, or drug interactions have been described in the literature for this transcript. Its presence as an antisense lncRNA might suggest some potential for *cis*-regulatory roles affecting SH2D3C expression, but this function is not established. This transcript is distinct from the protein-coding SH2D3C gene, which is an adaptor protein involved in cell signaling[5]; this lncRNA should not be confused with the protein target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to SH2D3C (ENSG00000299648).